Phibro Animal Health Corp (NASDAQ:PAHC) insider Jack Bendheim sold 20,000 shares of the stock in a transaction dated Thursday, September 6th. The stock was sold at an average price of $47.14, for a total transaction of $942,800.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Jack Bendheim also recently made the following trade(s):

  • On Tuesday, August 21st, Jack Bendheim sold 10,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $50.35, for a total transaction of $503,500.00.
  • On Thursday, August 23rd, Jack Bendheim sold 30,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $50.04, for a total transaction of $1,501,200.00.
  • On Monday, August 13th, Jack Bendheim sold 10,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $50.03, for a total transaction of $500,300.00.
  • On Wednesday, August 15th, Jack Bendheim sold 30,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $49.75, for a total transaction of $1,492,500.00.
  • On Monday, August 6th, Jack Bendheim sold 10,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $50.66, for a total transaction of $506,600.00.
  • On Wednesday, August 8th, Jack Bendheim sold 30,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $50.20, for a total transaction of $1,506,000.00.
  • On Wednesday, July 25th, Jack Bendheim sold 4,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $47.37, for a total transaction of $189,480.00.
  • On Friday, July 27th, Jack Bendheim sold 12,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $47.35, for a total transaction of $568,200.00.
  • On Thursday, July 19th, Jack Bendheim sold 17,470 shares of Phibro Animal Health stock. The stock was sold at an average price of $47.92, for a total transaction of $837,162.40.
  • On Monday, July 9th, Jack Bendheim sold 10,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $46.96, for a total transaction of $469,600.00.

Phibro Animal Health stock traded down $0.15 during trading hours on Friday, hitting $46.50. 712 shares of the company traded hands, compared to its average volume of 142,430. The stock has a market cap of $1.92 billion, a price-to-earnings ratio of 26.84, a PEG ratio of 2.75 and a beta of 0.89. The company has a current ratio of 2.90, a quick ratio of 1.73 and a debt-to-equity ratio of 1.62. Phibro Animal Health Corp has a 1-year low of $32.05 and a 1-year high of $54.62.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Monday, August 27th. The company reported $0.46 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.42 by $0.04. The firm had revenue of $211.80 million for the quarter, compared to analysts’ expectations of $209.27 million. Phibro Animal Health had a net margin of 7.90% and a return on equity of 39.81%. Phibro Animal Health’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the company earned $0.39 EPS. research analysts expect that Phibro Animal Health Corp will post 1.8 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 26th. Shareholders of record on Wednesday, September 5th will be paid a dividend of $0.10 per share. The ex-dividend date is Tuesday, September 4th. This represents a $0.40 annualized dividend and a yield of 0.86%. Phibro Animal Health’s payout ratio is 22.99%.

A number of institutional investors have recently added to or reduced their stakes in PAHC. Bank of New York Mellon Corp boosted its position in shares of Phibro Animal Health by 3.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 349,574 shares of the company’s stock valued at $16,097,000 after purchasing an additional 10,895 shares in the last quarter. California Public Employees Retirement System boosted its position in shares of Phibro Animal Health by 7.6% during the 2nd quarter. California Public Employees Retirement System now owns 38,619 shares of the company’s stock valued at $1,778,000 after purchasing an additional 2,723 shares in the last quarter. Macquarie Group Ltd. boosted its position in shares of Phibro Animal Health by 16.3% during the 2nd quarter. Macquarie Group Ltd. now owns 9,998 shares of the company’s stock valued at $460,000 after purchasing an additional 1,400 shares in the last quarter. Cubist Systematic Strategies LLC bought a new position in shares of Phibro Animal Health during the 2nd quarter valued at about $255,000. Finally, Renaissance Technologies LLC boosted its position in shares of Phibro Animal Health by 18.2% during the 2nd quarter. Renaissance Technologies LLC now owns 634,500 shares of the company’s stock valued at $29,219,000 after purchasing an additional 97,700 shares in the last quarter. 50.50% of the stock is currently owned by hedge funds and other institutional investors.

A number of analysts recently weighed in on the stock. Zacks Investment Research raised shares of Phibro Animal Health from a “sell” rating to a “buy” rating and set a $53.00 price objective on the stock in a report on Thursday, August 30th. Morgan Stanley raised their target price on shares of Phibro Animal Health from $36.00 to $46.00 and gave the company an “underweight” rating in a research note on Wednesday, August 29th. BidaskClub cut shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Thursday, August 16th. Finally, Barclays raised their target price on shares of Phibro Animal Health from $31.00 to $33.00 and gave the company an “underweight” rating in a research note on Thursday, July 5th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $43.20.

About Phibro Animal Health

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Featured Story: Leveraged Buyout (LBO)

Insider Buying and Selling by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.